CISA published advisory ICSMA-20-254-01 on September 10, 2020, later revised as Update C, covering eight vulnerabilities across Philips IntelliVue patient monitors (MX100, MX400 to MX850, MP2 to MP90, X2 and X3, versions N and prior), Patient Information Center iX (PIC iX) B.02, C.02 and C.03, and PerformanceBridge Focal Point A.01. ERNW researchers and Germany's Federal Office for Information Security (BSI) are credited.

The highest score is CVE-2020-16212 (CWE-668, CVSS v3 6.8): the PIC iX surveillance station runs in kiosk mode, and someone with physical access can break out of it with limited privileges. CVE-2020-16228 (CWE-299, CVSS 6.0) means PIC iX, Focal Point and several IntelliVue monitors do not check whether a certificate has been revoked, so a compromised certificate keeps working.

Availability takes three hits. CVE-2020-16216 (CVSS 6.5) lets crafted input restart IntelliVue monitors. CVE-2020-16224 (CVSS 6.5) mishandles a length field and restarts the PIC iX application. CVE-2020-16220 (CVSS 3.5) crashes the certificate enrollment service, which leaves monitoring running but blocks new devices from enrolling.

The remainder are lower: improper authentication in PIC iX and Focal Point (CVE-2020-16222, CVSS 5.0), cross-site scripting in a read-only web application that could expose patient data (CVE-2020-16218), and CSV formula injection in exported files (CVE-2020-16214). Every path needs physical access to stations and monitors or access to the medical device network.

Philips released PIC iX C.03, an updated PerformanceBridge Focal Point, and IntelliVue N.00 and N.01, with an upgrade path through service for M.04. Certificate revocation reached PIC iX and Focal Point in 2023, with IntelliVue monitors scheduled for Q3 2024.

Four years from advisory to revocation checking on the bedside monitors shows how slowly PKI hygiene moves once devices are in the field.